Carotid Stents - A Global Market Perspective

NEW YORK, Jan. 29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Carotid Stents - A Global Market Perspective

http://www.reportlinker.com/p0164249/Carotid-Stents---A-Global-Market-Perspective.html

Reduced procedure time, fewer complications, and shortened duration of patient hospitalization are few factors contributing to the growing utilization of carotid stenting procedures. Advent of advanced technologies for carotid stent systems is expected to lead to higher prices for products, thereby enhancing the revenue generation capacity of the market. The carotid artery stents market is also expected to benefit significantly from the expanded coverage for asymptomatic patients.

These and other market data and trends are presented in "Carotid Stents: A Global Market Perspective" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

CAROTID STENTS BMR-1049

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. GLOBAL MARKET OVERVIEW AND ANALYSIS 3

Carotid Stents - A Nascent Market! 3

3. MARKET DYNAMICS 4

Factors Driving Carotid Stents Market 4

Clinical Trials & Regulatory Approvals to Accelerate Adoption 4

Broader Application of CAS 4

Benefiting From Less-Invasive Nature of Procedure 5

Acceptance by Various Medical Specialties 5

Market Challenges 5

Absence of Sufficient Clinical Data 5

Surgeons Wary of High-Risk CAS Procedures 5

Reimbursement Coverage Issue Hurdles Widespread Adoption 6

Fighting for CAS Domain 6

Training and Certification of Surgeons - A Major Hurdle 7

Stenting Procedure for Transient Ischemic Attacks - A

Continuing- Dilemma 7

4. COMPETITIVE SCENARIO 7

5. PRODUCT FACTS 8

6. MAJOR CLINICAL TRIALS/STUDIES 9

Clinical Trials - Key to Higher Adoption of Carotid Stents 9

Major Clinical Trials & Stent Devices Used 9

Guidant's CAPTURE Study 10

CAPTURE Study Results Hold Promise for Asymptomatic Patients 10

Boston Scientific's BEACH Trial 10

Abbott's ACT I Trial 11

CREST Clinical Trial 11

J&J's SAPPHIRE Clinical Trial 12

SAPPHIRE Study Proves Effectiveness of CAS in High-Risk

Patients 12

Other Trials 12

Medtronic's MAVErIC Trials Validate the Efficiency of

Exponent Carotid Stent 12

University of Massachusetts Conduct CAS Efficacy Study in

Elderly- Patients 13

CaRESS Study 13

7. CORPORATE DEVELOPMENTS 14

Boston Scientific Acquires EndoTex 14

KNC Obtains Expanded CE Mark Clearance for TriActiv® ProGuard™ 14

FDA Approves Protege® RX Carotid Stent from ev3 14

8. MAJOR PLAYERS 15

Abbott Vascular (US) 15

Boston Scientific Corporation (USA) 15

ev3, Inc. (USA) 15

Johnson & Johnson (USA) 15

Cordis Corporation (USA) 15

Kensey Nash Corporation (USA) 16

Medtronic, Inc. (USA) 16

9. GLOBAL MARKET ANALYTICS 16

10. THE UNITED STATES 18

Overview 18

Factors Affecting Growth 18

Reimbursement Scenario for CAS 18

Reimbursements currently offered by the Centers for

Medicare and Medicaid Services (CMS) 18

Restricted Reimbursement Coverage Limits CAS Penetration 18

CMS Proposes Expanded Reimbursement Coverage for Carotid

Stenting 19

Absence of Regulatory Approvals - A Major Challenge 20

Clinical Trials - Key to Higher Adoption of Carotid Stents 20

Latent Demand 20

Key Statistics 20

Major Carotid Stents & EPDs in the Market 21

US Carotid Stents Market - A Gradual Growth 21

Trends and Issues 22

Convenience in Deployment & Use - Critical for Higher Adoption 22

Rapid Exchange Capabilities Facilitate Effective Control

Over Procedures 22

Carotid Stents Assume the Role of Memory Boosters 22

Competitive Landscape 23

11. EUROPE 25

European Carotid Stents Market - An Overview 25

ELOCAS Study 25

CEA Versus CAS 25

12. REST OF WORLD 27

Carotid Stenting Scenario in India 27

EXHIBITS

Table 1: Market Shares of Leading Players in the Global

Carotid Stents Market - 2007E

Table 2: Percentage Breakdown of Number of Carotid

Interventions Procedures Worldwide -2008E

Table 3: Global Carotid Stents Market by Region for the

Period 2007-2012 (Number of Procedures in Thousands)

Table 4: Percentage Breakdown (in Number) of Global Carotid

Stents Market by Region for the Years 2008 & 2012

Table 5: Global Carotid Stents Market by Region for the

Period 2007-2012 (Sales in US$ Million)

Table 6: Percentage Breakdown (in Revenue) of Global Carotid

Stents Market by Region for the Years 2008 & 2012

Table 7: Percentage Breakdown of Number of Carotid

Interventions Procedures in the US - 2008

Table 8: Market Shares of Leading Players in the US Market

for Carotid Stents - 2007

Table 9: Carotid Stents Market in the US: 2007-2012 (Number of

Procedures in Thousands)

Table 10: Carotid Stents Market in the US: 2007-2012 (Sales in

US$ Million)

Table 11: Percentage Breakdown of European Vascular

Interventions Market -2006E (Number of Procedures)

Table 12: Carotid Stents Market in Europe: 2007-2012 (Number

of Procedures in Thousands)

Table 13: Carotid Stents Market in Europe: 2007-2012 (Sales in

US$ Million)

Table 14: Carotid Stents Market in Rest of World: 2007-2012

(Number of Procedures in Thousands)

Table 15: Carotid Stents Market in Rest of World: 2007-2012

(Sales in US$ Million)

COMPANIES PROFILED

To order this report:

Medical Equipment and Supply Industry: Carotid Stents - A Global Market Perspective

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

SOURCE Reportlinker

21%

more press release views with 

Request a Demo